Kalon @Kalonshaka Twitter profile | Pikagi

Pikagi

Kalon

@Kalonshaka

226

Followers

6

Following

15

Media

761

Statuses

Years of R&D experience (not an advisor of any kind, just my opinions based on heavy research)

Joined June 2024

Don't wanna be here? Send us removal request.

Pinned Tweet

@Kalonshaka

Kalon

16 days

$SAVA @elonmusk summarizing Cassava Science Long (SAVAGE) Thesis as well as thoughts on the existing clinical data below: I have discussed about the extremely high potency of Cassava’s small molecule drug candidate, simufilam, against its protein target in comparison to a vast

11

30

119

Last Seen Profiles

@ethereansOS

@Rexia

@__kay__Official

@bokeplokalmalam

@stw_pdg

@SumerianRecords

@epicsansgaming2

@sludge__feast

@AdahW24427

@Costureria_F1

@anammostarac

@kawaiiale

@uimarupe__

@beafandraw

@dril

@Trekkw2ks

@iontouch

@JAMSHAID3670

@KhadyKoyo

@Tante_Binal69

@Mias3525

@LIL_NESTOR

@dmermis06

@RusWaterExperts

@ZackOswaldo

@MCookerly61801

@bokeplokalmalam

@bokeplokalmalam

@AC_assettocorsa

@bokeplokalmalam

@AMuratsuchi

@ch_aija

@lhwksz18747

@jandakembangstw

@Bcohen93

@sreyya3434

@Kalonshaka

Kalon

12 days

$SAVA @elonmusk The Wallstreet forces against Cassava Sciences are MIND BOGGLING! I discussed about the illegal collusive short and distort against Cassava Sciences by Wallstreet while Cassava continues to showcase from phase 2 program extremely compelling data cognition and

3

20

103

@Kalonshaka

Kalon

15 days

$SAVA @elonmusk I don’t particularly care if stock market players legally short a stock, as this is what historically has made the US stock market. But with Cassava Sciences it’s blatantly obvious that many Hedgefunds are illegally COLLUDING to short sell and naked short sell

@Kalonshaka

Kalon

16 days

$SAVA @elonmusk summarizing Cassava Science Long (SAVAGE) Thesis as well as thoughts on the existing clinical data below: I have discussed about the extremely high potency of Cassava’s small molecule drug candidate, simufilam, against its protein target in comparison to a vast

11

30

119

7

12

82

@Kalonshaka

Kalon

2 months

@MattNachtrab @elonmusk As we continue to defend the nonsense from the short attack against $SAVA , we must show the facts that a tiny fraction of preclinical studies of SAVA’s IND relate to Dr. Wang/Cuny

Tweet media one

6

14

79

@Kalonshaka

Kalon

21 days

$SAVA @elonmusk @MattNachtrab The Cassava phase 3 (rethink) study of Simufilam will be groundbreaking in mild-moderate Alzheimer’s. But I am also looking forward to future cholesterol and atherosclerosis studies of Simufilam given the following information of the impact of FLNA

3

9

76

@Kalonshaka

Kalon

28 days

@elonmusk $SAVA I discussed about the vastly profound impact of Simufilam on FLNA biology and cellular processes here I talked about the extreme high probability that Simufilam will achieve a minimum (worst-case) a statistical significant ( p < 0.05)

@Kalonshaka

Kalon

29 days

@elonmusk i joined premium X membership, hopefully you pay attention to the science behind $SAVA. All the info below can be verified through google searches of relevant publications. The unprecedented Phase 2 Open Label cognition effects of simufilam in Alzheimer’s through the

3

9

45

6

17

72

@Kalonshaka

Kalon

18 days

$SAVA @elonmusk Something to consider as we try to understand the unprecedented results we are seeing with simufilam in Alzheimer’s and as we await phase 3 outcomes. That a vast majority of known small molecule drugs bind to their target proteins or receptors in the

4

9

67

@Kalonshaka

Kalon

21 days

$SAVA @elonmusk @MattNachtrab I have talked about the profound role that Simufilam’s pico/femto molar concentration activity has against FLNA, FLNA phosphorylation (shown by University of Milan), FLNA fragments and resulting impact on Hypoxia Inducible Factor (HIF), as well as

1

6

67

@Kalonshaka

Kalon

29 days

@elonmusk perhaps this will get your ATTENTION ON $SAVA ! This is the minimum scenario for phase 3 (Rethink Phase 3 study) outcome success that the short HFs are betting against (they are basically saying Sava won’t achieve this): Placebo treatment group AdasCog mean

4

14

64

@Kalonshaka

Kalon

22 days

@elonmusk $SAVA The info below from perplexity (AI) shows and PROVES (with supporting scientific publication) that corrupt Wallstreet’s (Hedgefunds) short and distort against Cassava Sciences and DOJ indictment of Dr, Wang at CUNY is a ruse and a disgrace to our market as well

1

14

59

@Kalonshaka

Kalon

18 days

$SAVA These are the type of lunatics the wallstreet hedgefunds have hired to spread lies and FUD about cassava sciences. 😂 They are TOAST!

Tweet media one

3

5

49

@Kalonshaka

Kalon

10 days

$SAVA still trying to wrap my head around this…throw every single ounce of mud at the wall and see what sticks…DOJ indictment. 2 M pages and 3 terabytes of data? All for $250K worth of NIH grant money and based on one fraud count?….This is absurd

@MattNachtrab

Matt Nachtrab

10 days

Dr. Wang, $sava collaborator, Request for Support from Court for Subpoena of CUNY Lab Records gives an outline of the defenses case... the records at CUNY to include "admissible evidence that is directly exculpatory, including audit trails verifying that Dr. Wang's work was

Tweet media one

Tweet media two

16

9

106

3

3

48

@Kalonshaka

Kalon

1 month

@MattNachtrab The shit is gonna hit the fan for $SAVA shorts. The only word to describe is….KARMA!

1

4

45

@Kalonshaka

Kalon

29 days

@elonmusk i joined premium X membership, hopefully you pay attention to the science behind $SAVA. All the info below can be verified through google searches of relevant publications. The unprecedented Phase 2 Open Label cognition effects of simufilam in Alzheimer’s through the

3

9

45

@Kalonshaka

Kalon

2 months

@MattNachtrab I thank god $SAVA is at a point where the world will see the phase 3 data results, nothing stopping. Rethink phase 3 (800 patients) by end of year and Refocus (1200 patients) mid 2025. @elonmusk prepare for breakthrough In Alzheimer’s

0

5

44

@Kalonshaka

Kalon

1 month

Largest transfer of wealth from short hedgefunds to Investors of $SAVA in history of market in its infancy!🥳

@MattNachtrab

Matt Nachtrab

1 month

Here is an analysis of $sava value after approval and achieving 14-20% of the low TAM estimates. @MomentousTrader did an analysis of revenue multiples of many other big pharma companies. $sava would have to show they have the capability to deliver these goals but the share

11

17

96

0

3

43

@Kalonshaka

Kalon

18 days

And as I understand, Pharma is not Matt’s area of core competence. His deep research has convinced Matt that there’s an evil short and distort against $SAVA and that simufilam is the real McCoy! Bravo Matt!

@MattNachtrab

Matt Nachtrab

18 days

My Schedule 13G of $sava is filed and live.

Tweet media one

37

17

226

0

4

40

@Kalonshaka

Kalon

19 days

$SAVA @elonmusk Expanding on the below appended post (and publication) that proves multiple conformations of FLNA exist (through non phosphorylated FLNA and phosphorylated FLNA) and is consistent with Cassava Science proposed mechanism of action behind simufilam. Furthermore,

@Kalonshaka

Kalon

22 days

@elonmusk $SAVA The info below from perplexity (AI) shows and PROVES (with supporting scientific publication) that corrupt Wallstreet’s (Hedgefunds) short and distort against Cassava Sciences and DOJ indictment of Dr, Wang at CUNY is a ruse and a disgrace to our market as well

1

14

59

2

5

38

@Kalonshaka

Kalon

2 months

Well said. It’s the craziest short and distort I have ever seen. The data so far tells us phase 3 will be a success and will know for sure in 4-5 months. the shorts are acting the fools with their 199th accusation of $SAVA

@MattNachtrab

Matt Nachtrab

2 months

@elonmusk , we could use your help with a company that has a phase 3 #Alzheimers treatment that has experienced the most evil short seller attack I have been able to find. The families in in the trial are speaking out saying their family members are improving on the drug and

33

48

144

1

10

38

@Kalonshaka

Kalon

24 days

$SAVA whats Susquehanna doing here😂💣

Tweet media one

4

6

37

@Kalonshaka

Kalon

28 days

Agree will all except “inexpensive”. $SAVA has a right to charge a premium for the Alzheimer’s breakthrough they have developed especially in light of the fact of the short and distort for over 3 years and @SECGov @GaryGensler and @DOJCrimDiv effectively trying to slow down

@Archisaurus_YMB

Archisaurus YMB

@Archisaurus_YMB

28 days

After a discussion in @JoeSpringer 's discord, I decided to take a stab at creating a logo for $SAVA's promising #Alzheimer 's drug (currently in P3 trial homestretch). Generic #simufilam name would be supplanted by a new/marketable brand name after FDA approval.

Tweet media one

9

14

106

3

6

37

@Kalonshaka

Kalon

11 days

@MattNachtrab Shorts are indeed 100% wrong and they know it hence all the effort for over 3 years to stop $SAVA. I have seen all the lies and FUD for years first hand and well aware of every thing and the kitchen sink they have thrown. Any one that knows the data and FLNA science which is

0

3

36

@Kalonshaka

Kalon

1 month

$AVXL reports data from their phase 2b/3. Little do they know that their drug likely binds FLNA more weakly than $SAVA simufilam. Note their other molecule 3-71 is very close structurally to simufilam. Avxl 2b/3 vastly less robust that SAVA’s phase 3.

Tweet card media

All roads lead to Rome: compounds from AVXL and SAVA likely target the same sets of molecules —...

Cassava Sciences (SAVA) presented the phase 2b data on its lead drug, Sumifilam, from its re-analysis. The results look impressive from the view of biomarkers, although the new analysis is not...

www.biotechtoinvest.com

2

6

35

@Kalonshaka

Kalon

2 months

None of $SAVA any cognition data collected in phase 2 impacts Dr. Wang. Nor does the Phase 3 trials. The DOJ is following a hoax that the short and distort created

@TruthfulHand

Truthful Hand - Early Approval for SAVA Simufilam

2 months

Remember, @CassavaSciences Cognition Maintenance Study in 2022/2023 for #Simufilam was double-blind with full custody of data; entered directly from trial sites into independent database - Dr Wang nor anyone from $SAVA went anywhere near any of the data.

Tweet media one

4

10

57

1

7

32

@Kalonshaka

Kalon

2 months

$SAVA @elonmusk @SECGov @DOJCrimDiv this has been happening almost every single day for past 3 years..WTF!

@Mctoolman55

*toolman

2 months

Now Over 1M borrowed trying to hold $SAVA down! Market Makers use exception every week on Thursday and Friday to create shares. That is why it's trading at $10 when Phase 3 Alzheimer's data is about to drop, not the Short & Distort lies attacking the company for 3 years.

Tweet media one

3

5

25

3

8

32

@Kalonshaka

Kalon

2 months

@Hogie100 Investors know 100% about the bullshit short and distort on $SAVA AND we know the data is best the world has ever seen. Soon Phase 3 will finally prove it!

1

7

30

@Kalonshaka

Kalon

1 month

@annelisecrystal Unfortunately relatively small 3-arm trial with dose titration versus $SAVA no titration. $AVXL also had zero US sites. given explorat natures FDA will likely want a large Phase 3. $SAVA rethink Phase 3 (2 arm 800 patients) under FDA SPA reads out Q4! Game changer!

1

6

29

@Kalonshaka

Kalon

2 months

@MattNachtrab @rdohnethook Love this slide $SAVA

Tweet media one

1

2

29

@Kalonshaka

Kalon

1 month

no doubt about it! $SAVA

@Rick_in_Miami

Rickinmiami

1 month

$SAVA Getting some respect with new CEO and upcoming Phase 3 Readouts. Best potential Drug to stop #Alzheimer Disease progression. No side effects PT on Approval $500+ Current price $29 (should be $120) @alexandroskoure Maybe you could share with us Savages your TA of

Tweet media one

9

15

91

0

5

28

@Kalonshaka

Kalon

2 months

@elonmusk @MattNachtrab @DOJCrimDiv The JCI publication by the editor showcases the nefarious forces trying to smear scientific research based on image analysis, such as the ones against Thomas Sudhof and $SAVA. Even this piece is attacked on pubpeer!

1

6

27

@Kalonshaka

Kalon

1 month

@adamfeuerstein Cut the shit Adam turdfudstain! All investors know about the bogus short and distort now, no turning back $SAVA is real deal and P3 reads out out EOY! your HF colluders are toast!

1

0

23

@Kalonshaka

Kalon

1 month

@MattNachtrab Sad to see this $SAVA. Should continue imo to teach lesson to Wallstreet corruption. we all know discovery would lead to Point 72, citadel, arch etc

2

1

23

@Kalonshaka

Kalon

1 month

@Greatstockpix The only ones selling $SAVA was short sellers during that sell off, increasing their Short Interest liability by 4 million shares to 17 million shares short!

0

4

23

@Kalonshaka

Kalon

1 month

@adamfeuerstein You still mad about $SRPT eating short hedgefunds lunch…you aint seen any thing yet $SAVA

1

1

22

@Kalonshaka

Kalon

1 month

@elonmusk @TheRoaringKitty take a deep hard look at $SAVA. Thousands of SAVAges have crowd researched this like no other stock, it’s the real deal figting Short and distort and 10s of millions of naked shorts!

@MattNachtrab

Matt Nachtrab

1 month

Cassava Sciences, $SAVA, is a long term position for me because I believe their drug works. I have not sold a share since I posted my recent purchase. I believe it will prove effective in Phase 3 and will be a $40B drug or $833 a share. See below the three reasons I believe

Tweet media one

Tweet media two

Tweet media three

19

51

215

0

6

22

@Kalonshaka

Kalon

25 days

$SAVA @elonmusk the shit is gonna hint the fan for a lot of the folks involved in the SAVA short and distort and the millions of naked shorted shares!

@tiffinyfawcett

Tiffiny Fawcett

@tiffinyfawcett

25 days

$SAVA Great little video explanation on failure to deliver and how they affect stocks in the market.. and what happens if they squeeze 😉🍋🔥

0

7

44

3

3

22

@Kalonshaka

Kalon

30 days

$SAVA @elonmusk around 7 million new shorts since June for a total of 19 million shares shorted or 42% of the float! Retail is never selling. The recent price volatility is the shorts squealing around in their massive pit of filth!

@Mctoolman55

*toolman

30 days

This just dropped. $SAVA Short Interest 7/31 rose by 3M from last time. That is proof we were at 19.2M due to Shorting new CEO at $10. They still have not covered anything except Naked shorting more share using OPTIONS! Only WS can commit blatant crimes and @SECGov DOES NOTHING!

Tweet media one

6

8

30

2

7

22

@Kalonshaka

Kalon

1 month

@Malone_Wealth @SECGov @FBI @CIA @DHSgov $SAVA is the smoking gun. So much evidence that these criminals have been all over $SAVA short and distort

0

3

21

@Kalonshaka

Kalon

2 months

@MattNachtrab @elon 1000s $SAVA supporters know about the short and distort. Plus the Ortex data shows millions of shares borrowed/returned almost each and every day showing HF manipulation for 3 years. when you do the maths, <1% chance of P3 fails. Thats why they are trying so hard to stop

0

7

21

@Kalonshaka

Kalon

1 month

Mr. Barry and Dr. Kupiec were deadly assassins today. The $SAVA shorts were just just dec today and they do t even realize it! Stay tuned for the thumps!

@MattNachtrab

Matt Nachtrab

1 month

Great comments about $sava on one of the discussion boards. “Ok my day has settled down and here are my thoughts around the call. It was very well done. Barry and Kupiec as the main contributors to the content did outstanding! The transparency was clearly evident as well as

10

25

161

0

3

21

@Kalonshaka

Kalon

2 months

@7Innovator @7investing @MattNachtrab Given the immense market opportunity of simufilam, and disease modificatiin, a lot of investors are likely disappointed in a $10B buyout. Thats cheap!

0

0

20

@Kalonshaka

Kalon

1 month

@DueDoctor @steve2bacon Cut the shit, every investor knows about the short and distort against $SAVA and the shorts now using the weight of the government to indict based on blots and the original citizens petition.

0

2

19

@Kalonshaka

Kalon

1 month

@MattNachtrab Even $SAVA bashing Seeking Alpo authors going Long 😂

@meremrtl

Stephen Ayers

1 month

Fuck it. I’m going long $SAVA.

14

2

35

1

2

20

@Kalonshaka

Kalon

1 month

$SAVA @elonmusk @goodachar get a load of this. This has been happening over 3 years now. Shorts are toast!

@Mctoolman55

*toolman

1 month

Sure looks like someone printed shares of $SAVA this morning in order to hold SP down! Look at the buy of shares in min. 2 match the options. Then sold off 400K to ladder SP down. Short haven't covered anything! Looks like Manipulation. $GME & $NVDA this is next $TSLA @SECGov

Tweet media one

Tweet media two

5

8

44

0

6

20

@Kalonshaka

Kalon

1 month

$SAVA not to mention there’s been a gigantic amount of call options buying last few days, which means the market maker selling those calls have to buy shares on market to hedge those calls!

@Mctoolman55

*toolman

1 month

With Short Interest of 19.2M on 19.2M loaned out. 20%+ Gains last 6 of 7 days. $SAVA has now been ADDED to REG SHO list due to Failure to Deliver shares. REPOST THIS TO ALL YOUR FOLLOWERS. SAVA is due to for Massive Short Squeeze is going to happen. Cost to Borrow 369%

Tweet media one

0

47

108

0

8

20

@Kalonshaka

Kalon

2 months

@hokkeyplayer @thechartreaders @YouTube Just know it’s a massive short and distort against $SAVA going on 3 years. The science and biological activity behind simufilam has been corroborated by 3 Universties and cognition data handled by reputable third parties. Phase 3 will be fun!

1

4

19

@Kalonshaka

Kalon

2 months

Awesome!

@MattNachtrab

Matt Nachtrab

2 months

TLDR: $SAVA Remi resigned; Richard Barry in; SEC settlement near? I'm bullish. I added 400k shares this morning: 8K for $sava announced more details about CEO Remi Barbier's exit from the company. His resignation was deemed a "Other Than for Cause", so not for cause

Tweet media one

Tweet media two

Tweet media three

22

19

129

1

3

19

@Kalonshaka

Kalon

1 month

@SJ79716665 Mr. Barry and Dr. Kupiec were deadly assassins today for $SAVA. I expect that many instititions are now eyes and ears wide open to the significant milestones that Sava is barreling towards! I added to my position today!

0

2

19

@Kalonshaka

Kalon

2 months

@MattNachtrab The bashers have lied over and over against these facts by saying that the sponsor doesn’t have access to such data. We have always known why they have lied about this!

0

0

18

@Kalonshaka

Kalon

1 month

Classic example of not doing your due diligence and believe the bogus short and distort $SAVA

1

1

18

@Kalonshaka

Kalon

2 months

@MattNachtrab @JCVance3 Awesome, finally. Hope he can speak to these facts that we have been posting about in defense of $SAVA

0

0

18

@Kalonshaka

Kalon

1 month

@megtirrell $SAVA phase 3 results (rethink 800 patients) will shock the world in Q4 2024. There’s a massive short and distort ongoing for 3 years and $SAVA just extended their Phase 3 OLE studies!

1

7

16

@Kalonshaka

Kalon

21 days

@Jalkiboonde @elonmusk @MattNachtrab I don’t know the details on how exactly simufilam was discovered, however based on my experience cassava required two things. first, a FLNA screening assay and two, a library of synthesized molecules to screen. In fact we know that Cassava must have shared this FLNA screening

1

0

17

@Kalonshaka

Kalon

2 months

@MattNachtrab @MicrobiomDigest It’s out of control. And now @DOJCrimDiv has joined the bandwagon against $SAVA and Dr. Wang, when third party universities have corroborated the science that Sava has produced

0

2

17

@Kalonshaka

Kalon

2 months

These criminals of the short and distort against $SAVA have me blocked for a reason. bogus arguments now. They are pathetic and clearly don’t know any thing about patent enablement, which supports the claims with a multitude of studies listed in patents!

1

2

17

@Kalonshaka

Kalon

12 days

@MartinShkreli I don’t know you from Adam…but you mightbwant to start shaving!

@Kalonshaka

Kalon

16 days

$SAVA @elonmusk summarizing Cassava Science Long (SAVAGE) Thesis as well as thoughts on the existing clinical data below: I have discussed about the extremely high potency of Cassava’s small molecule drug candidate, simufilam, against its protein target in comparison to a vast

11

30

119

0

0

16

@Kalonshaka

Kalon

2 months

@7Innovator Please use any sample size stat calculator and enter reasonable assumptions on SD and differences between placebo and simu groups based on historical or ask A.I. with those same assumptions…chance of $SAVA P3 failure <1%!

1

1

16

@Kalonshaka

Kalon

2 months

@TEXTILE_FIBER @teslatesla111 @CathieDWood @ARKInvest A ton of complicit funds and institutions in this short and distort of $SAVA, all stemming from the fact that retail owns most of the float.

1

4

16

@Kalonshaka

Kalon

2 months

@elonmusk @BenAffleck @chrishemsworth this is what the corrupt short hedgfunds that are using the weight of the government @DOJCrimDiv to try to stop $SAVA large Phase 3 trials in Alzheimer’s. Supporters of Sava have been fighting. Given this 3 yr saga of corruption

@MattNachtrab

Matt Nachtrab

2 months

I'd like to clarify Open Label Extension Cassava Sciences, $sava, problem because I have had a few questions. Patients that enroll in the phase 3 trial can enroll into a 12 month open label extension trial. After they complete that trial, they no longer have access to

Tweet media one

10

25

103

4

4

16

@Kalonshaka

Kalon

8 days

@MattNachtrab This was a complete and utter thug shake down initiated by the short and distort and executed by Wallstreet against $SAVA, no doubt about it. The fact that the SEC and DOJ pawns of this for Wallstreet is extremely disturbing and disgusting. The whole cabal is going to look like

2

0

18

@Kalonshaka

Kalon

2 months

@TruthfulHand @CassavaSciences These criminals @adamfeuerstein and his colluders, along with DOJ trying to stop $SAVA. But nothing stopping phase 3!

2

1

15

@Kalonshaka

Kalon

1 month

The face of pure evil corruption $SAVA $RAPP

@ChrisRock002

ChrisRock002

1 month

$SAVA For all newcomers to SAVA, this is the man who is behind the destructive short & distort campaign against SAVA since July 2021 that made the sp drop 95%, Dr. Wang being indicted, Burns & Barbier leaving. It's all on him. Google Dr. Bredt Citizens Petition Cassava for more.

6

25

71

0

3

15

@Kalonshaka

Kalon

1 month

@adamfeuerstein have a look! $SAVA short and distort is ending very soon! Both drugs corroborate each other!

@Kalonshaka

Kalon

1 month

$AVXL reports data from their phase 2b/3. Little do they know that their drug likely binds FLNA more weakly than $SAVA simufilam. Note their other molecule 3-71 is very close structurally to simufilam. Avxl 2b/3 vastly less robust that SAVA’s phase 3.

2

6

35

1

5

15

@Kalonshaka

Kalon

2 months

Excellent post Matt!

@MattNachtrab

Matt Nachtrab

2 months

Masked Data Available to Sponsors / Why the $sava team could be very excited about the Phase 3 Blinded data People have asked how the sponsor ( $sava ) of an ongoing study might guess or infer whether a blinded study is indicating a possible treatment effect. Obviously, until

Tweet media one

Tweet media two

Tweet media three

Tweet media four

8

16

112

0

2

15

@Kalonshaka

Kalon

2 months

$SAVA I and thousands of Longs believe this is a slam dunk based on the prior data trends in cognition. And even at only this minimal 15% difference (though I believe it will be much much higher) that this will be clinically meaningful (clinically significant) due to safety

0

0

14

@Kalonshaka

Kalon

29 days

@LaraWil21150779 It’s beyond ludicrous and I don’t believe for one second that corrupt Wallstreet believes it for one second. collusion to suppress $SAVA value. Phase 3 ends this collusion!

1

0

14

@Kalonshaka

Kalon

2 months

@CGandhi2004 @LogarithmicDis @Thatsregrettab1 @SEC_Enforcement @MattNachtrab Log is a vile criminal as part of the short and distort against $SAVA

1

5

14

@Kalonshaka

Kalon

2 months

@LaraWil21150779 That eshaan Rao basher gonna get his former company sued. Can’t wait!

1

0

13

@Kalonshaka

Kalon

23 days

@stephmase22 This is all going to blow up for citadel, Arch, Susquehanna, point 72 etc when $SAVA reports phase 3 or even before. The crooks made the biggest mistake in history of market shorting $SAVA

6

3

13

@Kalonshaka

Kalon

1 month

@annelisecrystal $AVXL launching in EU first if they get approval is backward to optimize value. $SAVA doesn‘t have this problem!

1

2

13

@Kalonshaka

Kalon

2 months

@adamfeuerstein You need facts Fudstain…phase 3 is coming!

@Kalonshaka

Kalon

2 months

@MattNachtrab @elonmusk As we continue to defend the nonsense from the short attack against $SAVA , we must show the facts that a tiny fraction of preclinical studies of SAVA’s IND relate to Dr. Wang/Cuny

Tweet media one

6

14

79

1

0

13

@Kalonshaka

Kalon

1 month

$SAVA

@Kalonshaka

Kalon

1 month

@lipa0902 @adamfeuerstein How about clinical sites asking for extension or how about the confirmed unprecedented pico-femto molar activity for a drug against Alzheimer’s? Still not convinced? How bout the replicated cognition trends? 🥳$SAVA

0

0

5

0

3

13

@Kalonshaka

Kalon

12 days

@stephmase22 @citsecurities @GaryGensler @SECGov Incredible corruption. And then the @SECGov @GaryGensler go after small companies like $SAVA from corrupt Hedgefund pressure (as part of their short and distort) for potential disclosure mistakes and $SAVA a pre-revenue bio is preparing for a $20M fine (or 20% of their available

1

3

13

@Kalonshaka

Kalon

2 months

@MattNachtrab If the DOJ produces witnesses, i wonder if they Would be fair game to discovery?

1

0

12

@Kalonshaka

Kalon

2 months

@jay61006293 @MattNachtrab @TheRoaringKitty $SAVA 48M float, 40% of oupstanding shares borrowed. Citadel and Pt. 72 have oversold the float multiple times. It only takes 20,000 investors to own an average of 2,500 shares each to get to 50M. 1000s of Savages own >10,000 shares. Just math!

2

2

13

@Kalonshaka

Kalon

1 month

@elonmusk @TheRoaringKitty no short covering means that institution or whales are putting significant buying pressure on $SAVA. The world is waking up to the short and distort for over 3 years!

@Mctoolman55

*toolman

1 month

The #6 % gainer in Nasdaq today was $SAVA! #11 across all markets! This Alzheimer's Pill is for real! $NVDA $GME $AAPL $INTC $AMZN $SNAP $MSFT $AMD & $PLTR should know this is the next $TSLA. World Game Changer for Healthcare! Still no Covering by Shorts!

Tweet media one

Tweet media two

1

11

30

0

8

12

@Kalonshaka

Kalon

2 months

@Skeeter206 @MattNachtrab @elonmusk There is a ton of info and data in that $SAVA IND, all supporting safety and efficacy to enter phase 3. Since the IND is confidential dossier, the shorts don’t have access to a vast majority of the data contained in that IND!

0

2

11

@Kalonshaka

Kalon

2 months

@qodeqs @MattNachtrab short and distort against $SAVA for 3 years, many of us have lived it and know all the details. All based on FUD and now weight of government. Luckily unprecedented biological activity potency which is consistent with the cognition data. Set up to shock the world!

0

1

12

@Kalonshaka

Kalon

1 month

@meremrtl This 🤡👆$SAVA

0

0

12

@Kalonshaka

Kalon

30 days

@elonmusk @TheRoaringKitty the short Hedgefunds won’t be able to buy back 19 million shares shorted even after an @SECGov bogus fine of $SAVA. Pure manipulation and SEC is empowering these crooked hedgefunds…corruption!

@MattNachtrab

Matt Nachtrab

30 days

As of July 31st 19.03 shares of $sava were short. 42.3% of float. All time high. This means a ton of longs have come into this stock. On June 28th the stock was $9. July 31st the price was $22. They added 6m shares short but the stock went up 133%. It eventually got to a

Tweet media one

6

16

85

1

4

12

@Kalonshaka

Kalon

2 months

@GeorgeTakei Unfortunately Mr. Takei, liberals behind Hedgefunds like citadel/point 72 are trying to destroy $SAVA an Alzheimers’s biotech with the weight of the government. Phase 3 readout in a few months. They control media. The corruption runs deep @SECGov Thank god for crowd-research!

4

5

12

@Kalonshaka

Kalon

1 month

@Benioff @salesforce @elonmusk Sandy supported $SAVA since the beginning as a Director and large shareholder. I am saddened that he passed and won’t be in our realm to witness a major step forward in Alzheimer's treatment for mankind. His legacy will live on!

@MattNachtrab

Matt Nachtrab

1 month

@Benioff @salesforce Sandy was a legend in IT and biotech. He was also on the board at Cassava Sciences that has a treatment for Alzheimer’s in Phase 3. He and his wife were dedicated to finding a cure to the horrible disease. She passed in 2018. They lived full lives and left a major positive

2

21

132

1

2

12

@Kalonshaka

Kalon

2 months

@TruthfulHand @GaryGensler @SECGov @CassavaSciences @GaryGensler @SECGov blatantly ignoring this and same time investigating $SAVA based on a corrupt short short by hedgefunds who borrow millions shares each day to control share price? Repeat of @elonmusk

0

3

11

@Kalonshaka

Kalon

2 months

@Nine9_Tailed @BrianOrelli @EndAlzFraud @7Innovator @TheJusticeDept WTF are you talking about. This has negligible impact to $SAVA IND. They have sufficient MOA data from U. Of Milan and Cochin Institute. Criminal Shorts want to waste time. Phase 3 shows the world, soon!

1

2

12

@Kalonshaka

Kalon

2 months

@MicrobiomDigest it’s interesting that you unblocked me unlike your known short and distort cabal that tag one another. But could you please clarify how a $SAVA drug could show efficacy and still be a fraud scientifically? The whole cabal is full of inconsistencies 🤔

Tweet media one

2

1

12

@Kalonshaka

Kalon

2 months

@RonBurg26977072 @jesse_brodkin The guy is a scoundrel. He’s either doesn’t know about the concept of patent enablement or he knows and lies nonetheless…scoundrel!

0

2

11

@Kalonshaka

Kalon

2 months

@MattNachtrab @elonmusk Matt, Elon is a science man we need to show him the third party data. Here’s one from U. of Milan showing potent inhibition of FLNA phosphorylation at pico-molar concentration (lowest conc. tested). Google or ask AI what FLNA phosprylation does!

0

4

11

@Kalonshaka

Kalon

2 months

@elonmusk @elonmusk you must read the plethora of FLNA papers that others besides $SAVA have published. They show the criticality of FLNA for cell membrane structure and FLNA is involved many different processes, incl hypoxia, metastasis, immune response!

1

6

11

@Kalonshaka

Kalon

2 months

@SassiItalyTours @LaraWil21150779 Lots of buying pressure yesterday with 52% short volume and no covering. Who’s buying $SAVA💪

0

3

11

@Kalonshaka

Kalon

1 month

@SECGov @GaryGensler $SAVA what is our govt doing? Corrupt AF

@Mctoolman55

*toolman

1 month

Today after a good CC Short sellers attacked driving $SAVA down 21%. It's almost recovered b/c they were naked shares. Being on Reg. SHO list for last 9 days @SECGov & @GaryGensler allow MMer's to continue manipulating. Last 4 days over 1M Exceptions while on SHO! FTD's Huge!

Tweet media one

4

8

35

0

2

11

@Kalonshaka

Kalon

2 months

This is complete and utter bullshit! The required preclinical studies listed out, only a tiny fraction are impacted by Dr. W/Cuny. The biomarkers for phase 2b were inspected by the FDA and no further action by fda!

2

0

11

@Kalonshaka

Kalon

1 month

@MattNachtrab @BillE78059 we know for a fact that Sava submitted a protocol amendment to their IND as they stated it so in the $SAVA PR. Either it was a notification to the FDA or approval to the FDA doesn’t matter one iota, as the FDA has endorsed it!

1

2

10

@Kalonshaka

Kalon

2 months

Both of these disgusting short and distort criminals have me blocked so I can reply directly to their posts. They can’t read or understand or lie about that CUNY/Dr. Wang matter a tiny fraction to $SAVA IND!

4

0

10

@Kalonshaka

Kalon

8 days

@Greg94Flood @LaraWil21150779 @MattNachtrab complete bullshit! There are no later stage per inclusion criteria. And the cohorts of mild and moderate have been stratified prospectively which means you bet your ass that $SAVA can indeed do a separate mild and moderate analysis for stat sig. But the risk of P3 failure on

0

3

11

@Kalonshaka

Kalon

1 month

@invest331 Cut the shit..short and distort is coming to an end!

0

0

10

@Kalonshaka

Kalon

2 months

@Mctoolman55 @TeamTrump and why is @DOJCrimDiv indicting Dr. Wang and probing $SAVA, when their science and biological activity on simufilam has been corroborated by 3 other academic researchers (Yale, U. Of Milan, and Cochin Inst)? Sava IND has a tiny fraction related to CUNY!

@Kalonshaka

Kalon

2 months

@MattNachtrab @elonmusk As we continue to defend the nonsense from the short attack against $SAVA , we must show the facts that a tiny fraction of preclinical studies of SAVA’s IND relate to Dr. Wang/Cuny

Tweet media one

6

14

79

1

3

10

@Kalonshaka

Kalon

1 month

@adamfeuerstein @Leo09416981 You think $AVXL is a problem….it corroborates $SAVA more than you’ll ever know with your political science degree. $SAVA is gonna blow you away!

0

0

8

@Kalonshaka

Kalon

1 month

@MattNachtrab These numbers even the most conservative for $SAVA explains the immense efforts by short entities to slow or destroy sava.

0

0

9

@Kalonshaka

Kalon

1 month

@lipa0902 @RonBurg26977072 @adamfeuerstein Did you know the Cuny/Dr. Wang work has a negligible impact to Sava preclinical data in their IND? Hope you lose your ass off! 🤡

0

3

9

@Kalonshaka

Kalon

1 month

@LuoshengPeng $SAVA short and distort coming to an end…

1

0

9